![]() |
市場調查報告書
商品編碼
2000433
寵物基因檢測和祖源分析服務市場預測至2034年-按產品類型、檢測類型、檢體類型、技術、最終用戶和地區分類的全球分析Pet Genetic Testing & Ancestry Services Market Forecasts to 2034 - Global Analysis By Product, By Test Type, By Sample Type, By Technology, By End User and By Geography |
||||||
根據 Stratistics MRC 的數據,全球寵物基因檢測和血統追蹤服務市場預計到 2026 年將達到 4.8 億美元,在預測期內以 15.6% 的複合年成長率成長,到 2034 年將達到 15.2 億美元。
寵物基因檢測和溯源服務透過DNA分析,辨識寵物的品種組成、遺傳特徵、健康風險和祖先來源。這些服務使用唾液或血液樣本,深入了解遺傳疾病、行為傾向和營養需求。檢測結果有助於寵物飼主和獸醫就預防保健、訓練和飲食計劃做出明智的決策。先進的基因組技術和資料庫提高了檢測的準確性和個人化程度。人們對寵物健康的日益關注以及寵物「擬人化」的趨勢,推動了對這些服務的需求,從而促進了積極主動、數據驅動的寵物護理管理。
人們對識別寵物品種的興趣日益濃厚
寵物飼主,尤其是飼養混種犬的主人,越來越關注愛犬的血統、起源和獨特特徵。基因檢測有助於了解特定犬種的行為模式、飲食需求以及潛在的健康風險。隨著寵物越來越“擬人化”,飼主也更願意投資先進的診斷和分析服務。此外,個人化寵物照護方案的日益普及也推動了犬種鑑定試劑盒的需求。社群媒體的趨勢以及寵物血統鑑定結果在社群內的共用,進一步激發了消費者的興趣,並促進了市場的擴張。
寵物飼主缺乏意識
許多寵物飼主,尤其是發展中國家的寵物主人,並不了解基因檢測的益處。他們認為此類服務並非必需或屬於奢侈品,這阻礙了基因檢測的普及。此外,缺乏預防遺傳疾病和針對特定品種寵物的健康護理知識也阻礙了市場滲透。獸醫在基因檢測方面的指導不足也降低了消費者的信心。這些因素共同導致市場成長放緩,尤其是在對價格敏感的新興經濟體。
與獸醫醫療平台合作
基因檢測數據與獸醫記錄相結合,可為寵物提供個人化的健康護理方案。這種整合有助於早期發現遺傳疾病,從而改善預防保健和治療效果。獸醫醫院和數位寵物健康平台可以利用基因資訊提供個人化的營養管理和健康計劃。遠端醫療和數位健康生態系統的興起進一步促進了數據的無縫共用和分析。這些進步有望提升基因檢測服務的提案,並推動其在全球的普及應用。
影響消費者信任的準確性問題
調查方法的差異和品種資料庫的缺失會導致結果不一致且不可靠。品種誤判和健康風險預測不準確會導致寵物飼主不滿。此類不準確之處會損害品牌信譽並降低復購率。此外,缺乏標準化的法規和品質標準也增加了誤導性宣傳的風險。應對這些挑戰對於維護消費者信任和確保市場的長期永續性至關重要。
新冠疫情對寵物基因檢測和血統鑑定服務市場產生了複雜的影響。初期,供應鏈中斷和獸醫就診限制影響了產品分銷和服務供應。然而,疫情封鎖期間寵物飼養量的激增顯著擴大了潛在基本客群。居家時間增多的寵物飼主更重視寵物的健康狀況和血統資訊。電子商務平台的興起推動了家用DNA檢測套組的銷售。此外,疫情期間人們對預防性醫療保健意識的提高也促進了對基因檢測服務的需求。整體而言,疫情加速了市場的數位化,並帶來了長期成長機會。
在預測期內,DNA檢測套組細分市場預計將佔據最大的市場佔有率。
由於DNA檢測套組盒為寵物飼主提供了便利性和易用性,預計在預測期內,該細分市場將佔據最大的市場佔有率。這些試劑盒允許在家中採集檢體,無需頻繁前往獸醫診所。價格實惠且易於使用的檢測套組的日益普及推動了其應用。各公司不斷創新,以提供更快、更準確的檢測結果。直接面對消費者(D2C)模式的日益普及也進一步促進了該細分市場的成長。此外,強大的線上分銷管道也提高了產品在全球市場的可近性。
在預測期內,獸醫院細分市場預計將呈現最高的複合年成長率。
在預測期內,由於獸醫診所對基因檢測服務的參與度不斷提高,因此獸醫診所板塊預計將呈現最高的成長率。獸醫診所提供專家指導,從而提高了檢測結果的準確性和可靠性。寵物飼主預防保健意識的增強推動了診所對基因檢測的需求。將基因數據整合到常規獸醫護理中進一步促進了該服務的使用。診所也提供包含基因篩檢的綜合健康套餐。預計這一趨勢將顯著加速該板塊的成長。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其較高的寵物擁有率和消費者較高的寵物意識。主要市場參與者的存在以及先進的獸醫基礎設施為該地區的成長提供了支撐。該地區的寵物飼主願意為優質的醫療和預防保健服務付費。寵物「擬人化」趨勢的日益成長也推動了對基因檢測解決方案的需求。此外,成熟的電子商務和直銷管道提高了產品的供應量。有利的法規環境也進一步鞏固了該地區的市場主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於快速的都市化和不斷成長的可支配收入。寵物擁有率的提高,尤其是在新興經濟體,正在擴大基本客群。人們對寵物健康和福祉的日益關注,推動了基因檢測服務的使用。獸醫基礎設施和數位醫療平台的擴張也為市場成長提供了支持。此外,全球企業和本土Start-Ups的進入加劇了市場競爭。這些因素共同促成了亞太地區成為市場成長最快的地區。
According to Stratistics MRC, the Global Pet Genetic Testing & Ancestry Services Market is accounted for $0.48 billion in 2026 and is expected to reach $1.52 billion by 2034 growing at a CAGR of 15.6% during the forecast period. Pet Genetic Testing & Ancestry Services involve DNA-based analysis to identify a pet's breed composition, genetic traits, health risks, and ancestry. These services use saliva or blood samples to provide insights into inherited conditions, behavioral tendencies, and nutritional needs. Results help pet owners and veterinarians make informed decisions regarding preventive healthcare, training, and diet planning. Advanced genomic technologies and databases enhance accuracy and personalization. Growing awareness of pet health and the humanization of pets are driving demand for these services, supporting proactive and data-driven pet care management.
Rising interest in pet breed identification
Pet owners are increasingly curious about the lineage, heritage, and unique traits of their pets, particularly for mixed-breed animals. Genetic insights help in understanding behavioral patterns, dietary requirements, and potential health risks associated with specific breeds. The growing humanization of pets is encouraging owners to invest in advanced diagnostic and analytical services. Additionally, the popularity of personalized pet care solutions is boosting demand for breed identification kits. Social media trends and community sharing of pet ancestry results are further amplifying consumer interest and market expansion.
Limited awareness among pet owners
Many pet owners, especially in developing regions, are unfamiliar with the benefits of genetic testing. The perception that such services are non-essential or luxury offerings restricts widespread adoption. Lack of education regarding genetic disease prevention and breed-specific healthcare also hampers market penetration. Furthermore, limited availability of veterinary guidance on genetic testing reduces consumer confidence. These factors collectively slow down market growth, particularly in price-sensitive and emerging economies.
Integration with veterinary healthcare platforms
Genetic testing data can be combined with veterinary records to provide personalized healthcare plans for pets. This integration enables early detection of hereditary diseases, improving preventive care and treatment outcomes. Veterinary clinics and digital pet health platforms can leverage genetic insights to offer tailored nutrition and wellness programs. The rise of telemedicine and digital health ecosystems further supports seamless data sharing and analysis. Such advancements are expected to enhance the value proposition of genetic testing services and expand their adoption globally.
Accuracy issues affecting consumer trust
Variations in testing methodologies and limited breed databases can lead to inconsistent or unreliable results. Incorrect breed identification or health risk predictions may lead to dissatisfaction among pet owners. Such inaccuracies can damage brand credibility and reduce repeat purchases. Additionally, lack of standardized regulations and quality benchmarks increases the risk of misleading claims. Addressing these challenges is crucial for maintaining consumer trust and ensuring long-term market sustainability.
The COVID-19 pandemic had a mixed impact on the pet genetic testing and ancestry services market. Initially, supply chain disruptions and restrictions on veterinary visits affected product distribution and service accessibility. However, the surge in pet adoption during lockdowns significantly increased the potential customer base. Pet owners spending more time at home showed greater interest in understanding their pets' health and ancestry. The rise of e-commerce platforms facilitated the sale of home-based DNA testing kits. Additionally, growing awareness of preventive healthcare during the pandemic boosted demand for genetic testing services. Overall, the pandemic accelerated digital adoption and long-term growth opportunities in the market.
The DNA testing kits segment is expected to be the largest during the forecast period
The DNA testing kits segment is expected to account for the largest market share during the forecast period as it offers convenience and ease of use for pet owners. These kits enable sample collection at home, eliminating the need for frequent veterinary visits. Increasing availability of affordable and user-friendly testing kits is driving widespread adoption. Companies are continuously innovating to provide faster and more accurate results. The growing popularity of direct-to-consumer models is further supporting segment growth. Additionally, strong online distribution channels are enhancing product accessibility across global markets.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate due to increasing professional involvement in genetic testing services. Veterinary clinics provide expert guidance, improving the accuracy and reliability of test results. Growing awareness of preventive healthcare among pet owners is driving demand for clinic-based testing. Integration of genetic data into routine veterinary care is further enhancing service adoption. Clinics are also offering comprehensive health packages that include genetic screening. This trend is expected to accelerate the growth of this segment significantly.
During the forecast period, the North America region is expected to hold the largest market share owing to high pet ownership rates and strong consumer awareness. The presence of leading market players and advanced veterinary infrastructure supports regional growth. Pet owners in the region are more willing to spend on premium and preventive healthcare services. The increasing trend of pet humanization is also driving demand for genetic testing solutions. Additionally, well-established e-commerce and direct-to-consumer distribution channels enhance product accessibility. Favorable regulatory frameworks further contribute to the dominance of this region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid urbanization and rising disposable incomes. Increasing pet adoption rates, particularly in emerging economies, are expanding the customer base. Growing awareness about pet health and wellness is encouraging the use of genetic testing services. The expansion of veterinary infrastructure and digital healthcare platforms supports market growth. Additionally, the entry of global players and local startups is intensifying market competition. These factors collectively position Asia Pacific as the fastest-growing region in the market.
Key players in the market
Some of the key players in Pet Genetic Testing & Ancestry Services Market include Basepaws, Inc., Embark Veterinary, Inc., Zoetis Inc., Neogen Corporation, Animal Genetics, Inc., Orivet Genetic Pet Care, DNA My Dog, Paw Print Genetics, PetGenoma, EasyDNA, IdentiGEN Ltd., Genoscoper Laboratories, Illumina, Inc., Thermo Fisher Scientific Inc. and Mapmygenome India Ltd.
In September 2024, Embark introduced a veterinarian- and geneticist-backed supplement range, marking its entry into broader pet health beyond DNA testing. This expansion positioned the company as a more holistic pet wellness provider.
In June 2022, Zoetis officially completed the acquisition of Basepaws. The deal strengthened Zoetis's portfolio by integrating Basepaws' genetic insights, enabling veterinarians and pet owners to better understand disease risks and improve early detection.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.